Hippocampus-sparing volume-modulated arc therapy in patients with World Health Organization grade II glioma: a feasibility study
Renxian Xie, Hongxin Huang, Qingxin Cai, Jiayang Lu, Tong Chen, Keyan Xie, Jianzhou Chen, Chuangzhen Chen · 2025
Read Hippocampus-sparing volume-modulated arc therapy in patients with World Health Organization grade II glioma: a feasibility study by Renxian Xie, Hongxin Huang, Qingxin Cai, Jiayang Lu, Tong Chen, Keyan Xie, Jianzhou Chen, Chuangzhen Chen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11788287.txt.
Description
Xie and seven co-authors tested a radiation planning method that spares the hippocampus in twenty twenty-four. The hippocampus, vital for memory, is sensitive to radiation. Patients with grade two glioma, a slow-growing brain tumor, live long enough that protecting memory matters greatly.
Using scans from ten treated patients, they built two arc therapy plans per patient: one steering dose away from the hippocampus, one standard. Plan quality measures matched between the two. The sparing plans sharply cut dose to both hippocampi, left and right. They also lowered dose to the brainstem and spinal cord. The authors say the approach is feasible and may lessen memory damage risk. Clinical trials must still confirm that memory is truly preserved.
Catalog record
| CREATOR | Renxian Xie, Hongxin Huang, Qingxin Cai, Jiayang Lu, Tong Chen, Keyan Xie, Jianzhou Chen, Chuangzhen Chen |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |